NASDAQ:DVAX
Dynavax Technologies Corporation
- Stock
locale
United Statesmarket
STOCKSindustry
Drug Manufacturers / Specialty & Genericwebsite
www.dynavax.comipo date
Feb 19, 2004
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the ad...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus